when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Eli Lilly and Co · news · pharmadog

← back to Eli Lilly and Co

News mentioning Eli Lilly and Co

71 stories

28dLilly preps FDA run for ‘triple-G’ weight loss drug with Phase 3 databiospace

29dMake or break: Commercial hires critical for successbiospace

29dBiopharma layoffs must double in H2 for 2026 to match 2025 cutsbiospace

29dQ2 earnings underway, FDA’s CRL kerfuffle, IPOs full speed ahead in H2biospace

Jul 20, 26Lilly’s AtaiBeckley buy validates space as Big Pharma takes note of psychedelicsbiospace

Jul 20, 26Scribe aims for $96M IPO to fund clinical push for lipid-lowering genetic medsfiercebiotech

Jul 20, 26Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independencebiospace

Jul 16, 26Lilly makes up to $3.8B psychedelics play in AtaiBeckley takeoverbiospace

Jul 16, 26Braveheart, Attovia, Vogenx keep IPOs ballooning with plans to compete in cardiometabolic, immunobiospace

Jul 15, 26J&J dips despite upbeat outlook; AstraZeneca, Spero cut China dealsbiopharma dive

Jul 7, 26Kailera says obesity pill succeeds in late-stage trial in Chinabiopharma dive

Jul 2, 26STAT+: Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitalsstat

Jul 2, 26The new presidential fitness test is a positive step, not the solution, experts saystat

Jul 1, 26STAT+: Booze schmooze: The alcohol industry, frazzled by headwinds, wields its power behind the scenesstat

Jun 30, 26Republican Tom Kean Jr. reveals depression diagnosis after his four-month absence from Congressstat

Jun 30, 26Eli Lilly, Fujifilm among seven selected for FDA’s PreCheck pilotendpoints

Jun 30, 26These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.biopharma dive

Jun 30, 26Half of states sue over Medicaid work requirementsstat

Jun 30, 26STAT+: Even with MAHA, Trump administration has gone soft on alcoholstat

Jun 30, 26STAT+: The loophole in Trump’s obesity drug deal with Eli Lilly and Novo Nordiskstat

Jun 29, 26FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturingfda press

Jun 29, 265 takeaways from STAT’s investigation into microhospital operator Nutex Healthstat

Jun 26, 26Alkermes’ incoming CEO has a plan to outplay Lilly and Takedabiopharma dive

Jun 18, 26STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and morestat

Jun 12, 26STAT+: Prometheus raises $12 billion in capital for artificial engineersstat

Jun 11, 26STAT+: Abridge inks deals with Nvidia and Lillystat

Jun 10, 26AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicinebiopharma dive

Jun 8, 26ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ optionbiopharma dive

Jun 4, 26Lilly, Boehringer retrench in Germany on proposed health spending cutsendpoints

Jun 3, 26Lilly, Ascidian link up in RNA exon editing pactbiopharma dive

← prevpage 2 of 3next →